Keyword: Gabriel Haering

Strategy & Management

Experts Statements: Gabriel Haering, Cerbios Pharma

05.09.2019 -

The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021.

Sites & Services

Life Science Valley in the Heart of Europe

24.11.2017 - Located just south of the Swiss Alps, Ticino is the Italian-speaking region of Switzerland. The canton’s strategic geographic position represents a bridge between northern and...

News

Cerbios joins CMC Biologics and IDT Biologika in ADC Collaboration

13.10.2016 - CMC Biologics and IDT Biologika announced the addition of Cerbios and Oncotec Pharma to PROVEO, their strategic collaboration for providing a complete and efficient solution to the...

Strategy & Management

CPhI 2014 Experts Statements:Dr. Gabriel Haering, CEO, Cerbios

01.10.2014 - 1. What roles do contract research organizations (CROs) and contract manufacturing organizations (CMOs) play in the drug discovery/development value chain today, and how will their...

Strategy & Management

Today’s Challenges, Tomorrow’s Excellence

01.10.2014 - Pharmaceutical companies have outsourced several critical steps in the discovery and development of new drugs and the scale-up of processes and the manufacturing of APIs. Pharma...

Plant Construction & Process Technology

Value Over Price

11.09.2013 - Quality First - As the trend of specialized medicine continues to grow, so does the development of highly potent active pharmaceutical ingredients, better known as HPAPIs. Handling...

News

Cerbios' New Manufacturing Plant Enters Qualification Phase

19.02.2013 - Cerbios-Pharma has announced that the construction phase for its new biotechnology plant in Barbengo (Switzerland) is almost concluded. The "state-of-the-art" biologics plant is...